Back to Search
Start Over
Self-administered intranasal medication to terminate supraventricular tachycardia.
- Source :
-
Lancet (London, England) [Lancet] 2023 Jul 08; Vol. 402 (10396), pp. 81-83. Date of Electronic Publication: 2023 Jun 15. - Publication Year :
- 2023
-
Abstract
- Competing Interests: SK has received research grants from Abbott Medical and Biotronik and speaker's honoraria from Biosense Webster, Abbott Medical, Biotronik, and Sanofi Aventis. TC has received speaker's honoraria from Biosense Webster.
Details
- Language :
- English
- ISSN :
- 1474-547X
- Volume :
- 402
- Issue :
- 10396
- Database :
- MEDLINE
- Journal :
- Lancet (London, England)
- Publication Type :
- Academic Journal
- Accession number :
- 37331367
- Full Text :
- https://doi.org/10.1016/S0140-6736(23)00823-1